BioScrip to Report Fourth Quarter and Year End 2006 Earnings on March 16
14 Mars 2007 - 8:32PM
Business Wire
BioScrip, Inc. (Nasdaq: BIOS) announced today that it will host a
conference call with financial analysts at 10:00 AM EDT on March
16, 2007, to discuss its operating results for the fourth quarter
and year ended December 31, 2006. BioScrip will issue a press
release announcing the operating results before market open on
March 16, 2007. Investors and other interested parties may
participate in the conference call by dialing 888-214-7562 (US), or
415-537-1852 (International), 5-10 minutes prior to the start of
the call. A replay of the conference call will be available from
12:30 PM EDT on March 16th through 11:59 PM EDT on March 22nd. The
replay may be accessed by dialing 800-633-8284 (US), or
402-977-9140 (International), and entering reservation #21333003.
Thereafter, a webcast of the conference call will be available in
the investors section of the BioScrip website at www.bioscrip.com.
About BioScrip, Inc. BioScrip provides comprehensive pharmaceutical
care solutions. We partner with healthcare payors, pharmaceutical
manufacturers, government agencies, physicians, and patients to
deliver cost effective programs that enhance the quality of patient
life. We focus our products and services in two core areas:
Specialty medication distribution and clinical management services,
both nationally and community-based, and Pharmacy Benefit
Management services. Our specialty medication distribution
capabilities include condition-specific clinical management
programs tailored to improve the care of individuals with complex
health conditions such as HIV/AIDS, Cancer, Infusion IVIG,
Hepatitis C, Rheumatoid Arthritis, Multiple Sclerosis, and
Transplantation. Our complete pharmacy benefit management programs
include customized benefit plan design, pharmacy network management
and sophisticated reporting capabilities that deliver improved
clinical and economic outcomes. In addition, we have 34 locations
including community and infusion pharmacies in major metropolitan
markets across the U.S., providing nationwide access and clinical
management capabilities in a high-touch community-based
environment. Forward Looking Statements This press release may
contain statements which constitute forward looking statements
within the meaning of the Private Securities Litigation Reform Act
of 1995, including statements regarding the intent, belief or
current expectations of the Company, its directors, or its officers
with respect to the future operating performance of the Company and
our success with respect to the integration and consolidation.
Investors are cautioned that any such forward looking statements
are not guarantees of future performance and involve risks and
uncertainties, and that actual results may differ materially from
those in the forward looking statements as a result of various
factors. Important factors that could cause such differences are
described in the Company's periodic filings with the Securities and
Exchange Commission.
BioPlus Acquisition (NASDAQ:BIOS)
Graphique Historique de l'Action
De Juin 2024 à Juil 2024
BioPlus Acquisition (NASDAQ:BIOS)
Graphique Historique de l'Action
De Juil 2023 à Juil 2024